212 related articles for article (PubMed ID: 32197723)
1. Integrating the Voice of the Patient Into the Medical Device Regulatory Process Using Patient Preference Information.
Benz HL; Saha A; Tarver ME
Value Health; 2020 Mar; 23(3):294-297. PubMed ID: 32197723
[TBL] [Abstract][Full Text] [Related]
2. Measuring Patient Preferences at the FDA Center for Devices and Radiological Health: Reflections and Projections.
Webber CM; Chen AL; Gebben DJ; Saha A; Tarver ME
Value Health; 2021 Jul; 24(7):1024-1029. PubMed ID: 34243826
[TBL] [Abstract][Full Text] [Related]
3. Incorporating patient-preference evidence into regulatory decision making.
Ho MP; Gonzalez JM; Lerner HP; Neuland CY; Whang JM; McMurry-Heath M; Hauber AB; Irony T
Surg Endosc; 2015 Oct; 29(10):2984-93. PubMed ID: 25552232
[TBL] [Abstract][Full Text] [Related]
4. Medical devices: US medical device regulation.
Jarow JP; Baxley JH
Urol Oncol; 2015 Mar; 33(3):128-32. PubMed ID: 25458071
[TBL] [Abstract][Full Text] [Related]
5. Regulation and Device Development: Tips for Optimizing Your Experience With the Food and Drug Administration.
Brooks SS
Tech Vasc Interv Radiol; 2017 Jun; 20(2):109-115. PubMed ID: 28673647
[TBL] [Abstract][Full Text] [Related]
6. Software-Related Recalls of Health Information Technology and Other Medical Devices: Implications for FDA Regulation of Digital Health.
Ronquillo JG; Zuckerman DM
Milbank Q; 2017 Sep; 95(3):535-553. PubMed ID: 28895231
[TBL] [Abstract][Full Text] [Related]
7. Summary of the FDA virtual public workshop on spinal device clinical review held on September 17, 2021.
Devlin VJ; Jean R; Peat CR; Jiang H; Anderson PA; Benson JC; Brodke DS; Golish SR; Kebaish KM; Larson AN; Serhan H
Spine J; 2022 Sep; 22(9):1423-1433. PubMed ID: 35460900
[TBL] [Abstract][Full Text] [Related]
8. Use of Real-World Evidence for Regulatory Approval and Coverage of Medical Devices: A Landscape Assessment.
Timbie JW; Kim AY; Concannon TW
Value Health; 2021 Dec; 24(12):1792-1798. PubMed ID: 34838277
[TBL] [Abstract][Full Text] [Related]
9. Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA.
Janssens R; Russo S; van Overbeeke E; Whichello C; Harding S; Kübler J; Juhaeri J; Bywall KS; Comanescu A; Hueber A; Englbrecht M; Nikolenko N; Pravettoni G; Simoens S; Stevens H; Hermann R; Levitan B; Cleemput I; de Bekker-Grob E; Veldwijk J; Huys I
Patient; 2019 Oct; 12(5):513-526. PubMed ID: 31222436
[TBL] [Abstract][Full Text] [Related]
10. A Framework for Incorporating Patient Preferences Regarding Benefits and Risks into Regulatory Assessment of Medical Technologies.
Ho M; Saha A; McCleary KK; Levitan B; Christopher S; Zandlo K; Braithwaite RS; Hauber AB;
Value Health; 2016; 19(6):746-750. PubMed ID: 27712701
[TBL] [Abstract][Full Text] [Related]
11. Assessment of US Food and Drug Administration-Approved Digital Medical Devices for Just-in-Time Interventions: A Systematic Review.
Phi NTT; Oikonomidi T; Ravaud P; Tran VT
JAMA Intern Med; 2023 Aug; 183(8):858-869. PubMed ID: 37459057
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
Rathi VK; Krumholz HM; Masoudi FA; Ross JS
JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
[TBL] [Abstract][Full Text] [Related]
13. FDA marketing claims, and the practitioner.
Runner S
J Evid Based Dent Pract; 2006 Mar; 6(1):19-23. PubMed ID: 17138391
[TBL] [Abstract][Full Text] [Related]
14. Incremental Revisions across the Life Span of Ophthalmic Devices after Initial Food and Drug Administration Premarket Approval, 1979-2015.
Gopal AD; Rathi VK; Teng CC; Del Priore L; Ross JS
Ophthalmology; 2017 Aug; 124(8):1237-1246. PubMed ID: 28501378
[TBL] [Abstract][Full Text] [Related]
15. ISPOR, the FDA, and the Evolving Regulatory Science of Medical Device Products.
O'Neill T; Miksad R; Miller D; Maloney L; John A; Hiller C; Hornberger J
Value Health; 2019 Jul; 22(7):754-761. PubMed ID: 31277820
[TBL] [Abstract][Full Text] [Related]
16. Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions-Report of the ISPOR Stated Preference Research Special Interest Group.
Marsh K; van Til JA; Molsen-David E; Juhnke C; Hawken N; Oehrlein EM; Choi YC; Duenas A; Greiner W; Haas K; Hiligsmann M; Hockley KS; Ivlev I; Liu F; Ostermann J; Poder T; Poon JL; Muehlbacher A
Value Health; 2020 Jul; 23(7):831-841. PubMed ID: 32762984
[TBL] [Abstract][Full Text] [Related]
17. Regulatory scripting: Stakeholder participation in food and drug administration medical device advisory meetings.
White SK; Leiter V; Le MH; Helms CK
PLoS One; 2023; 18(2):e0281774. PubMed ID: 36795788
[TBL] [Abstract][Full Text] [Related]
18. How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?
Samuel AM; Rathi VK; Grauer JN; Ross JS
Clin Orthop Relat Res; 2016 Apr; 474(4):1053-68. PubMed ID: 26584802
[TBL] [Abstract][Full Text] [Related]
19. Leveraging Patient Preference Information in Medical Device Clinical Trial Design.
Rincon-Gonzalez L; Selig WKD; Hauber B; Reed SD; Tarver ME; Chaudhuri SE; Lo AW; Bruhn-Ding D; Liden B
Ther Innov Regul Sci; 2023 Jan; 57(1):152-159. PubMed ID: 36030334
[TBL] [Abstract][Full Text] [Related]
20. New FDA draft guidance on premarket submissions.
Donawa ME
Med Device Technol; 1999 Oct; 10(8):12-4. PubMed ID: 10724773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
